GOG 3007, a randomized phase II (RP2) trial of everolimus...

GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent endometrial carcinoma (EC): A GOG Foundation study

Slomovitz, B.M., Filiaci, V.L., Coleman, R.L., Walker, J.L., Fleury, A.C., Holman, L.L., Miller, D.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
149
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2018.04.012
Date:
June, 2018
File:
PDF, 193 KB
english, 2018
Conversion to is in progress
Conversion to is failed